Canadian Clinical Drug Data Set - HL7 Terminology (THO) v6.3.0

HL7 Terminology (THO)
6.3.0 - Publication International flag

HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 6.3.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions

NamingSystem: Canadian Clinical Drug Data Set

Official URL: http://terminology.hl7.org/NamingSystem/CCDD				Version: 1.1.0
Active as of 2024-11-04			Responsible: Health Canada	Computable Name: CCDD

The Canadian Clinical Drug Data Set provides codes for identification and a consistent approach to naming of medications and some medical devices in Canada. It has been designed and developed to reflect current clinical practice and safety advice and is freely available for use in digital health solutions and design applications. CCDD is available in English and Canadian French.

To request content changes, send an email to clinicaldrug@infoway-inforoute.ca.

Canada Health Infoway has developed a FHIR representation of CCDD, which can be viewed at: https://ontoserver.csiro.au/shrimp/launch.html?iss=https://terminologystandardsservice.ca/fhir

The CCDD FHIR representation contains supplemental property codes, as defined in the Health Canada Drug Product Database (DPD), managed by Health Canada, as follows:

Anatomical Therapeutical Chemical (ATC): The purpose of the ATC classification system is to be used as a tool for drug utilization research to improve the quality of drug use.
Biosimilar: Identifies biosimilar products.
Pediatric: Identifies pediatric products.
Schedule: Each drug is assigned one or more schedules according to the Food and Drug Regulations and the Controlled Drugs and Substances Act.

Further information on the supplemental properties may be obtained by reviewing the information at https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html or by emailing pharma_drug_enquiries-renseignements_medicaments_pharma@hc-sc.gc.ca

Generated Narrative: NamingSystem CCDD

Summary

Defining URL

http://terminology.hl7.org/NamingSystem/CCDD

Version

1.1.0

Name

CCDD

Title

Canadian Clinical Drug Data Set

Status

active

Definition

The Canadian Clinical Drug Data Set provides codes for identification and a consistent approach to naming of medications and some medical devices in Canada. It has been designed and developed to reflect current clinical practice and safety advice and is freely available for use in digital health solutions and design applications. CCDD is available in English and Canadian French.

To request content changes, send an email to clinicaldrug@infoway-inforoute.ca.

Canada Health Infoway has developed a FHIR representation of CCDD, which can be viewed at: https://ontoserver.csiro.au/shrimp/launch.html?iss=https://terminologystandardsservice.ca/fhir

The CCDD FHIR representation contains supplemental property codes, as defined in the Health Canada Drug Product Database (DPD), managed by Health Canada, as follows:

Anatomical Therapeutical Chemical (ATC): The purpose of the ATC classification system is to be used as a tool for drug utilization research to improve the quality of drug use.
Biosimilar: Identifies biosimilar products.
Pediatric: Identifies pediatric products.
Schedule: Each drug is assigned one or more schedules according to the Food and Drug Regulations and the Controlled Drugs and Substances Act.

Further information on the supplemental properties may be obtained by reviewing the information at https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html or by emailing pharma_drug_enquiries-renseignements_medicaments_pharma@hc-sc.gc.ca

Publisher

Health Canada